header photo Cave Creek 7/24/2019 5:00:07 PM
News / CBD

CBD Dog Treats For Large And Small Dogs Are Scientifically Formulated For Targeted Delivery

CBD Unlimited’s pure hemp extracted CBD dog treats for large and small dogs is scientifically formulated to be the purest CBD soft chews for dogs available. Derived from 100% certified pure hemp, our CBD dog treats can introduce your furry family members to all the potential medicinal benefits of cannabidiol.

All of our cannabidiol products, including our full range of Phyto-Bites CBD pet treats, use 100% pure hemp. Cannabidiol used by CBD Unlimited is taken from hemp thoroughly tested by third party laboratories for potency and purity, furthermore certified 100% pure by the State of Arizona.

Each and every Phyto-Bites product is packed with between 2-5mg of concentrated cannabidiol in each and every peanut butter flavored bite! Our Phyto-Bites CBD dog treats can be purchased in varieties for large and small dogs, cats and travel tins for pet owners always on the go.

Become your furry family members best advocate for health, become the dog owner your pup knows you to be and keep them healthy with the help of Phyto-Bites CBD dog treats from CBD Unlimited. Cannabidiol infused into the CBD soft chews are the purest for your pets health, delivering targeted delivery where needed most.

About CBD Unlimited, Inc.

CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over a half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.

In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.

Websites include: www.cbdunlimited.com, and www.phytobites.com.

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.

For further investor and media information, contact:

CBD Unlimited, Inc.

Todd Davis

Chairman & CEO

info@cbdunlimited.com

480-999-0097